INTRODUCTION: [(18)F]Nifene is a novel radiotracer specific to the nicotinic acetylcholine α4β2 receptor class. In preparation for using this tracer in humans we have performed whole-body PET studies in mice to evaluate the in vivo biodistribution and dosimetry of [(18)F]Nifene. METHODS: Seven BALB/c mice (3 males, 4 females) received IV tail injections of [(18)F]Nifene and were scanned for 2 h in an Inveon dedicated PET scanner. Each animal also received a high resolution CT scan using an Inveon CT. The CT images were used to draw volume of interest (VOI) on the following organs: brain, large intestine, small intestine, stomach, heart, kidneys, liver, lungs, pancreas, bone, spleen, testes, thymus, uterus and urinary bladder. All organ time activity curves had the decay correction reversed and were normalized to the injected activity. The area under the normalized curves was then used to compute the residence times in each organ. The absorbed doses in mouse organs were computed using the RAdiation Dose Assessment Resource (RADAR) animal models for dose assessment. The residence times in mouse organs were converted to human values using scale factors based on differences between organ and body weights. OLINDA 1.1 software was used to compute the absorbed human doses in multiple organs for both female and male phantoms. RESULTS: The highest mouse residence times were found in urinary bladder, liver, bone, small intestine and kidneys. The largest doses in mice were found in urinary bladder and kidneys for both females and males. The elimination of radiotracer was primarily via kidney and urinary bladder with the urinary bladder being the limiting organ. The projected human effective doses were 1.51E-02 mSv/MBq for the adult male phantom and 1.65E-02 mSv/MBq for the adult female model phantom. CONCLUSION: This study indicates that the whole-body mouse imaging can be used as a preclinical tool for initial estimation of the absorbed doses of [(18)F]Nifene in humans.
INTRODUCTION: [(18)F]Nifene is a novel radiotracer specific to the nicotinic acetylcholine α4β2 receptor class. In preparation for using this tracer in humans we have performed whole-body PET studies in mice to evaluate the in vivo biodistribution and dosimetry of [(18)F]Nifene. METHODS: Seven BALB/c mice (3 males, 4 females) received IV tail injections of [(18)F]Nifene and were scanned for 2 h in an Inveon dedicated PET scanner. Each animal also received a high resolution CT scan using an Inveon CT. The CT images were used to draw volume of interest (VOI) on the following organs: brain, large intestine, small intestine, stomach, heart, kidneys, liver, lungs, pancreas, bone, spleen, testes, thymus, uterus and urinary bladder. All organ time activity curves had the decay correction reversed and were normalized to the injected activity. The area under the normalized curves was then used to compute the residence times in each organ. The absorbed doses in mouse organs were computed using the RAdiation Dose Assessment Resource (RADAR) animal models for dose assessment. The residence times in mouse organs were converted to human values using scale factors based on differences between organ and body weights. OLINDA 1.1 software was used to compute the absorbed human doses in multiple organs for both female and male phantoms. RESULTS: The highest mouse residence times were found in urinary bladder, liver, bone, small intestine and kidneys. The largest doses in mice were found in urinary bladder and kidneys for both females and males. The elimination of radiotracer was primarily via kidney and urinary bladder with the urinary bladder being the limiting organ. The projected human effective doses were 1.51E-02 mSv/MBq for the adult male phantom and 1.65E-02 mSv/MBq for the adult female model phantom. CONCLUSION: This study indicates that the whole-body mouse imaging can be used as a preclinical tool for initial estimation of the absorbed doses of [(18)F]Nifene in humans.
Authors: Kasia M Bieszczad; Ritu Kant; Cristian C Constantinescu; Suresh K Pandey; Hideki D Kawai; Raju Metherate; Norman M Weinberger; Jogeshwar Mukherjee Journal: Synapse Date: 2012-02-15 Impact factor: 2.562
Authors: Kai Kendziorra; Henrike Wolf; Philipp Mael Meyer; Henryk Barthel; Swen Hesse; Georg Alexander Becker; Julia Luthardt; Andreas Schildan; Marianne Patt; Dietlind Sorger; Anita Seese; Herman-Josef Gertz; Osama Sabri Journal: Eur J Nucl Med Mol Imaging Date: 2010-11-11 Impact factor: 9.236
Authors: Bernard Le Foll; Svetlana I Chefer; Alane S Kimes; Dean Shumway; Elliot A Stein; Alexey G Mukhin; Steven R Goldberg Journal: Biol Psychiatry Date: 2008-12-18 Impact factor: 13.382
Authors: A G Horti; U Scheffel; A O Koren; H T Ravert; W B Mathews; J L Musachio; P A Finley; E D London; R F Dannals Journal: Nucl Med Biol Date: 1998-10 Impact factor: 2.408
Authors: Alexey G Mukhin; Alane S Kimes; Svetlana I Chefer; John A Matochik; Carlo S Contoreggi; Andrew G Horti; D Bruce Vaupel; Olga Pavlova; Elliot A Stein Journal: J Nucl Med Date: 2008-09-15 Impact factor: 10.057
Authors: Patrick J Lao; Tobey J Betthauser; Dana L Tudorascu; Todd E Barnhart; Ansel T Hillmer; Charles K Stone; Jogeshwar Mukherjee; Bradley T Christian Journal: Synapse Date: 2017-04-26 Impact factor: 2.562
Authors: V Galitovskiy; S A Kuruvilla; E Sevriokov; A Corches; M L Pan; M Kalantari-Dehaghi; A I Chernyavsky; J Mukherjee; S A Grando Journal: J Cancer Res Ther (Manch) Date: 2013-05-29
Authors: Anthony-David T Campoy; Christopher Liang; Reisha M Ladwa; Krystal K Patel; Ishani H Patel; Jogeshwar Mukherjee Journal: Molecules Date: 2021-12-04 Impact factor: 4.411
Authors: Mathias Kranz; Bernhard Sattler; Solveig Tiepolt; Stephan Wilke; Winnie Deuther-Conrad; Cornelius K Donat; Steffen Fischer; Marianne Patt; Andreas Schildan; Jörg Patt; René Smits; Alexander Hoepping; Jörg Steinbach; Osama Sabri; Peter Brust Journal: EJNMMI Phys Date: 2016-10-21
Authors: Sang Hee Lee; Nunzio Denora; Valentino Laquintana; Giuseppe Felice Mangiatordi; Angela Lopedota; Antonio Lopalco; Annalisa Cutrignelli; Massimo Franco; Pietro Delre; In Ho Song; Hye Won Kim; Su Bin Kim; Hyun Soo Park; Kyungmin Kim; Seok-Yong Lee; Hyewon Youn; Byung Chul Lee; Sang Eun Kim Journal: Eur J Nucl Med Mol Imaging Date: 2021-11-16 Impact factor: 9.236
Authors: Tobey J Betthauser; Ansel T Hillmer; Patrick J Lao; Emily Ehlerding; Jogeshwar Mukherjee; Charles K Stone; Bradley T Christian Journal: Nucl Med Biol Date: 2017-08-17 Impact factor: 2.408